A. G. Baykova

A. G. Baykova

Auto-generated profile, based on publicly available information

A. G. Baykova

Samara State Medical University

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2020 in Russian Journal of Occupational Health and Industrial Ecology
Verified
Journal Article
Closed access
PDF file
LSL. A. Strizhakov
L. A. Strizhakov
SBS. A. Babanov
S. A. Babanov
DBD. S. Budash
D. S. Budash
MLMarina V. Lebedeva
Marina V. Lebedeva
ABA. G. Baikova
A. G. Baikova
SMSergey V. Moiseev
Sergey V. Moiseev
Иммунологические особенности и прогнозирование при современных формах профессиональных заболеваний легких

1 September 2021 in Russian Journal of Occupational Health and Industrial Ecology
Verified
Journal Article
Closed access
PDF file
SBSergey A. Babanov
Sergey A. Babanov
LSLeonid A. Strizhakov
Leonid A. Strizhakov
ABAntonina G. Baikova
Antonina G. Baikova
DBDarya S. Budash
Darya S. Budash
AAAnna S. Agarkova
Anna S. Agarkova
MVMarina Yu. Vostroknutova
Marina Yu. Vostroknutova
Introduction. Occupational asthma is a complex and heterogeneous disease. Development of personalized treatment and prevention tactics becomes feasible due to phenotyping, which means identifying of markers to combine cases of occupational asthma with similar manifestations (clinical, instrumental, laboratory) and prognosis to phenotypes. The study aims to determination and comparative analysis of spirographic and immunological parameters for different phenotypes of occupational asthma. Materials and methods. In this study, we included 170 patients with different phenotypes of occupational asthma and 50 participants in control group. The spirographic examination was performed using computer spirograph with determination of the following parameters: forced vital capacity (FVC), forced expiratory volume during the first second (FEV1), Tiffeneau-Pinelli index (FEV1/FVC), peak expiratory flow (PEF), maximal expiratory flow at 75%, 50%, 25% of the forced vital capacity (MEF75%VC, MEF50%VC, MEF25%VC). Quantification of the immunoglobulins IgA, IgM, and IgG in human serum was conducted by Mancini method; levels of IgE, C-reactive protein and fibronectin were determined using a solid-phase enzyme immunoassay. Fibrinogen concentration in plasma was measured by an automatic coagulometer. Haptoglobin concentration in serum was determined by spectrophotometry. Results. According to spirometry and laboratory results obtained, there is a strong evidence, that the phenotype "occupational asthma - occupational chronic obstructive pulmonary disease" has the lowest values in pulmonary function tests and the most significant changes in immunoglobulins, fibronectin and acute phase proteins levels among other studied phenotypes of occupational asthma. Conclusions. Dynamic determination of spirometric, immunological parameters, fibronectin and proteins of the acute phase of inflammation in workers at risk for the formation of occupational bronchial asthma may be recommended to be carried out once every 6 months, followed by the isolation of disease phenotypes. This will optimize diagnostics, therapeutic and preventive tactics, as well as predict the course of this pathology.

1 August 2020 in Sanitarnyj vrač (Sanitary Doctor)
Verified
Journal Article
Closed access
ABAntonina Gennadievna Baikova
Antonina Gennadievna Baikova
MVMarina Yurievna Vostroknutova
Marina Yurievna Vostroknutova
DBDinara Kolgarovna Borisova
Dinara Kolgarovna Borisova
SBSergey Anatolievich Babanov
Sergey Anatolievich Babanov
The article is devoted to the study of spirographic indicators FEV1, FEV1/FVC, PEF, MEF75, MEF50, MEF25 as the most informative indicators reflecting the state of bronchial patency at the level of the proximal and distal parts of the bronchial tree in various phenotypes of professional bronchial asthma. Signs of respiratory distress are most pronounced in patients with the phenotype «PBA-occupational chronic obstructive pulmonary disease». Significantly,the» most favorable «spirographic picture in terms of FVC, FEV1, PEF, and MEF25VC is observed in the «PBA allergic» phenotype. Dynamic determination of speed indicators of forced expiration in various phenotypes of professional bronchial asthma can improve the diagnosis of obstructive disorders in this pathology, optimize the choice of treatment and prevention tactics, and predict the course of this pathology.

31 March 2023 in Hygiene and sanitation
Verified
Journal Article
Open access
PDF file
АМАндрей Владимирович Мелентьев
Андрей Владимирович Мелентьев
SBSergey A. Babanov
Sergey A. Babanov
ABAntonina G. Baykova
Antonina G. Baykova
NLNatalia E. Lavrentyeva
Natalia E. Lavrentyeva
Introduction. Occupational asthma has long been considered as a separate, independent disease, but in recent years, more and more attention is paid to its heterogeneity. Molecular genotyping opens up new possibilities in the search for a more targeted and personalized approach to the treatment of occupational asthma, and in the development of an individual strategy for its prevention. The aim of the study was to determine genetic markers of the risk of developing occupational bronchial asthma under exposure to sensitizing substances by assessing polymorphic variants rs2069812 of the IL-5 gene and polymorphic variants rs1837253 of the TSLP gene. Materials and methods. The study was conducted in one hundred seventy patients with various phenotypes of occupational bronchial asthma and 50 people in the control group. Genotyping was performed by real-time polymerase chain reaction using primers and probes developed using the PrimerQuest program (Intergrated DNA Technologies, Inc.). Results. For the first time, genetic markers of the risk for occupational bronchial asthma under exposure to sensitizing substances were identified to include polymorphic variants rs2069812 of the IL-5 gene and polymorphic variants rs1837253 of the TSLP gene. It makes it possible to recommend the determination of these genetic markers during in-depth periodic medical examinations in people working under conditions of exposure to sensitizing and irritating substances in the presence of clinical and functional, immunological changes. Limitations. The study has regional (Samara region) and occupational (detailed working conditions in the studied comparison groups) limitations. Conclusion. The identified marker profiles of occupational asthma genotypes can optimize the approach to diagnosis, treatment, and prevention of this pathology, and expand the range of criteria for predicting the course of the disease.

28 February 2025
Verified
Journal Article
Closed access
SBS. A. Babanov
S. A. Babanov
ABA. G. Baykova
A. G. Baykova
S5Samara Sbhi Sr Samara City Hospital No. 5
Samara Sbhi Sr Samara City Hospital No. 5
MAM. S. Artemieva
M. S. Artemieva
ABA. S. Babanov
A. S. Babanov
Introduction. Currently, occupational bronchial asthma is considered as a phenotypically and genetically heterogeneous disease. The assessment of clinical data, functional features, and immunopathogenesis opens up new opportunities in assessing the development, predicting the characteristics of the course, and working out a personalized approach to pharmacotherapy of occupational asthma, as well as in developing an individual strategy for its prevention. The purpose of the study is to determine clinical and immunological markers of the risk of developing occupational asthma under conditions of exposure to sensitizing substances in various phenotypes of this disease. Materials and methods. The study included 170 patients with various OA phenotypes and 50 participants in the control group. The pulmonary function test was carried out on the CareFusion MicroLab Desktop Spirometer (Great Britain). The levels of IL-17, TNF-α, vascular endothelial growth factor (VEGF), MCP-1, IFN-γ, and total IgE in blood serum were determined by solid-phase enzyme immunoassay using kits and reagents (OOO «Protein contour», «Vector-Best», «Diatex-E», «DIA-plus», «Pharmacia diagnostika»). Results. For the first time, the features of clinical and immunological manifestations in allergic and non-allergic OA phenotypes, as well as phenotypes of OA combination with occupational chronic obstructive pulmonary disease and metabolic syndrome were established; the features of formation, immunopathogenesis, and prognosis in various phenotypes of occupational bronchial asthma were revealed. This allows recommending the determination of these immunological parameters during in-depth periodic medical examinations of workers under conditions of exposure to sensitizing and irritating substances for differential diagnosis of various phenotypes of occupational bronchial asthma in a specialized inpatient examination. Limitations of the study. The study has regional (Samara Region) and professional (in terms of detailing working conditions in the studied comparison groups) limitations. Conclusion. The identified clinical, immunological, and genotypic features in various OA phenotypes and the established profiles of OA genotypes can optimize the approach to early diagnosis, prognosis, prevention, and pharmacotherapy of this disease, as well as expand the list of immunological study indicators used during preliminary and periodic medical examinations, in-depth examination of patients with occupational bronchial asthma in occupational disease clinics and occupational pathology centers, and the application of new reliable criteria for predicting the course of the disease

6 April 2023 in Terapevt (General Physician)
Verified
Journal Article
Closed access
SBS. A. Babanov
S. A. Babanov
FFFSBEI HE Samara State Medical University of the Ministry of Health of the Russian Federation
FSBEI HE Samara State Medical University of the Ministry of Health of the Russian Federation
ABA. G. Baikova
A. G. Baikova
LSL. A. Strizhakov
L. A. Strizhakov
AAA. S. Agarkova
A. S. Agarkova
Introduction. Currently, despite the fact that occupational asthma has long been considered as a separate, independent disease, recent studies pay more and more attention to its heterogeneity. Occupational asthma phenotyping was originally based on the identification of combinations of clinical characteristics of the disease, but now more and more data that allow understanding the cause of clinical differences at the molecular genetic level are emerging. Thus, molecular genotyping opens up new opportunities in the search for a more targeted and personalized approach to the treatment of occupational asthma, as well as in the development of an individual strategy for its prevention. The aim of the study was to determine the genetic risk markers for the development of oc cupational asthma under the influence of sensitizers by assessing the TSLP gene polymor phism rs1837253. Materials and methods. The study was conducted on the basis of the Department of Occupational Diseases and Clinical Pharmacology named after honored scientist of the Russian Federation professor V. V. Kosarev, FSBEI HE Samara State Medical University of the Ministry of Health of the Russian Federation, and the Department of Occupational Pathology, SBHI SR Samara Medical and Sanitary Unit No. 5 of the Kirovsky District. The study involved 170 patients with various phenotypes of occupational bronchial asthma (OBA) and 50 people in the control group: group 1 (42 people) — the phenotype «allergic occupational bronchial asthma», group 2 (36 people) — the phenotype «non-allergic occupational bronchial asthma», group 3 (58 people) — the phenotype «occupational bronchial asthma — occupational chronic obstructive pulmonary disease», group 4 (34 people) — the phenotype «occupational bronchial asthma — metabolic syndrome», group 5 (50 people) — the control group (healthy). As part of the study of genetic predisposition to occupational bronchial asthma,genetic polymorphisms of the rs1837253 TSLP gene were determined. DNA samples were isolated from peripheral venous blood lymphocytes by phenol-chloroform extraction. Genotyping was performed by real-time polymerase chain reaction using primers and probes developed with the PrimerQuest tool (Integrated DNA Technologies, Inc.). Results. Thus, for the first time, genetic risk markers for the development of occupational asthma under the influence of sensitizers have been identified: the TSLP gene polymorphisms rs1837253, which makes it possible to recommend determining these genetic markers during in-depth periodic medical examinations in persons working under exposure to sensitizing and irritating substances in the presence of clinical, functional, and immunological changes. Conclusion. The identified marker profiles of OBA genotypes can optimize the approach to the diagnosis, treatment and prevention of this pathology, as well as expand the range of criteria for predicting the course of the disease. If polymorphisms of the TSLP gene are detected during molecular genetic studies, patients need to be registered with a dispensary and require repeated examinations of the function of external respiration once every 6 months and in-depth periodic medical examinations in a specialized center of occupational pathology with the obligatory participation of a pulmonologist, an allergist-immunologist, an occupational pathologist, as well as conducting extended functional and immunological studies once every 2 years.